Cuba vs Latvia: Death rate from Parkinson's disease
Cuba
6.77 deaths per 100,000 people
in 2021
Latvia
6.7 deaths per 100,000 people
in 2021
Cuba rank
45th
Latvia rank
46th
Death rate from Parkinson's disease over time
- Cuba
- Latvia
How they compare
Cuba currently reports 6.77 deaths per 100,000 people against 6.7 deaths per 100,000 people in Latvia, a difference of 0.07 deaths per 100,000 people.
The two have swapped places 4 times across 22 shared years of data; in 2000 it was Cuba ahead.
Cuba ranks 45th and Latvia ranks 46th of 194 countries.
Across the 3 decades both report, Cuba averaged higher in 2 and Latvia in 1.
Head to head by decade
| Decade | Cuba | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.68 deaths per 100,000 people | 1.87 deaths per 100,000 people | 0.812 deaths per 100,000 people | Cuba |
| 2010s | 4.8 deaths per 100,000 people | 3.75 deaths per 100,000 people | 1.05 deaths per 100,000 people | Cuba |
| 2020s | 6.53 deaths per 100,000 people | 6.94 deaths per 100,000 people | 0.405 deaths per 100,000 people | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from parkinson's disease, Cuba or Latvia?
- Cuba, at 6.77 deaths per 100,000 people against 6.7 deaths per 100,000 people in Latvia as of 2021.
- What is the difference in death rate from parkinson's disease between Cuba and Latvia?
- 0.07 deaths per 100,000 people, with Cuba ahead.
- How many years of comparable data are there for Cuba and Latvia?
- 22 years are reported by both, from 2000 to 2021.
- How do Cuba and Latvia rank globally for death rate from parkinson's disease?
- Cuba ranks 45th and Latvia ranks 46th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Death rate from Parkinson's disease. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from parkinson disease in both sexes, per 100,000 people.